Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akero Therapeutics Inc (DE:0K4)
FRANKFURT:0K4
RESEARCH TOOLSreports
Holding DE:0K4?
Track your performance easily
See the Price Targets and Ratings of:
0K4 Analyst Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0K4 Stock 12 Month Forecast
Average Price Target
€52.38
▲(93.29% Upside)
| Highest Price Target€62.72 | Average Price Target€52.38 | Lowest Price Target€36.66 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
Assigned
12/16/24
Morgan Stanley
Reiterated
11/21/24
H.C. Wainwright
Reiterated
11/18/24
Phillip Securities
Initiated
11/18/24
Bank of America Securities
Reiterated
11/12/24
Canaccord Genuity
Reiterated
11/10/24
LifeSci Capital
Reiterated
11/08/24
Wolfe Research
Assigned
06/10/24
J.P. Morgan
Reiterated
05/10/24
Cantor Fitzgerald
€34.74→€48.24
Buy
78.02%
Upside
Reiterated
03/04/24
Akero upside capped on bone mineral density questions, says CantorAkero upside capped on bone mineral density questions, says Cantor
UBS
€37.63→€40.52
Buy
49.54%
Upside
Reiterated
03/04/24
Akero Therapeutics (AKRO) PT Raised to $42 at UBSUBS analyst Eliana Merle raised the price target on Akero Therapeutics (NASDAQ: AKRO) to $42.00 (from $39.00) while maintaining a Buy rating.
Jefferies
€33.77→€48.24
Buy
78.02%
Upside
Reiterated
03/04/24
Akero Therapeutics price target raised to $50 from $35 at JefferiesAkero Therapeutics price target raised to $50 from $35 at Jefferies
Best Analysts Covering Akero Therapeutics
Which Analyst Should I Follow If I Want to Buy DE:0K4 and Sell After:
1 Month
xxx
Success Rate
12/21 ratings generated profit
Average Return
+1.23%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.23% per trade.
3 Months
xxx
Success Rate
5/8 ratings generated profit
Average Return
+5.74%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +5.74% per trade.
1 Year
Success Rate
5/8 ratings generated profit
Average Return
+21.75%
assigned a buy rating 7 days ago
Copying Liisa Bayko's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +21.75% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
Average Return
+12.11%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +12.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0K4 Analyst Recommendation Trends
Rating
Jun 24
Aug 24
Sep 24
Nov 24
Dec 24
Strong Buy
8
12
10
12
8
Buy
0
0
0
3
4
Hold
1
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
12
10
16
13
Each month's total comprises the sum of three months' worth of ratings.
0K4 Financial Forecast
0K4 Stock Forecast FAQ
What is DE:0K4’s average 12-month price target, according to analysts?
Based on analyst ratings, Akero Therapeutics Inc’s 12-month average price target is €52.38.
What is DE:0K4’s upside potential, based on the analysts’ average price target?
Akero Therapeutics Inc has 93.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Akero Therapeutics Inc a Buy, Sell or Hold?
Akero Therapeutics Inc has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Akero Therapeutics Inc’s share price target?
The average share price target for Akero Therapeutics Inc is €52.38. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €62.72 ,and the lowest forecast is €36.66. The average share price target represents 93.29% Increase from the current price of €27.1.
The highest analyst share price target is €62.72 ,and the lowest forecast is €36.66. The average share price target represents 93.29% Increase from the current price of €27.1.
What do analysts say about Akero Therapeutics Inc?
Akero Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Akero Therapeutics Inc?
To buy shares of DE:0K4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.